Mayo Clinic researchers say that the challenge of controlling heart disease among people may be greater than is commonly thought.
Cardiologist Francisco Lopez-Jimenez says that a study has revealed that the positive U.S. health trend documented over the past 30 years of reduction in risk for heart disease is not as strong as is widely perceived. According to him, the trend has instead flattened.
Mitral Valve Stenosis And Mitral Valve Replacement
Mitral valve replacement is a surgical heart procedure to correct either the narrowing (stenosis) or the leakage (regurgitation).
Advertisement
"This study may surprise people because the data show that the risk of heart disease is not going down as we expected. The estimated risk in our nation was coming down nicely in the 1980s. Then around 2000 it began changing - the trend lines flattened. While we had done a nice job with lowering cholesterol, blood pressure and stopping smoking, over time the improvement in these risk factors slowed and others like diabetes and obesity emerged, threatening to undo the early progress we made in reducing risk of heart disease. Most of the gains in reducing heart disease risk have been offset by the increased prevalence of diabetes and obesity," he says.
While making a presentation at the American Heart Association's Scientific Sessions 2008 in New Orleans, he claimed that his team's study was the first to suggest that not as much progress against heart disease is being made in recent years, despite the efforts by many organizations to promote healthy lifestyles, and the wide availability and lower price of many cholesterol and blood pressure-lowering drugs.
![Mitral Valve Regurgitation and Mitral Valve Replacement]( "Mitral Valve Regurgitation and Mitral Valve Replacement")
Mitral valve replacement is replacing the diseased mitral valve with an artificial valve.
"This is highly relevant to public health because most people think the risk of heart disease is going down steadily and has for the past 30 to 40 years -but our data show something different," Dr. Lopez-Jimenez said.
"The fact is that despite all the wonderful things we've done - all the changes in fat consumption, the promotion of exercise, the quitting smoking, treatment of high cholesterol and blood pressure - it doesn't appear to be enough; the risk reduction we did achieve early on in the 1980s has gone flat, and we need to change that," he added.
For their study, the researchers compared national heart disease risk factor data from three time periods to track change over time in risk reduction.
While early period documented changes in risk between 1976 and 1980 and a midpoint of 1988 to 1994, the last period documented changes in risk from the midpoint to 1999 to 2004.
The team said that comparing changes from the early stage to the midpoint documented a decline in the overall risk to develop heart disease, but comparing change from the midpoint to the late period showed the trend flattening.
"No one has ever compared national data this way, which is why we are the first to detect this worrisome flattening of the trend in risk factor reduction," Dr. Lopez-Jimenez says.
He said that for women, in particular, the age-adjusted risk declined from the early period to the midpoint, but stayed flat from the midpoint to the late period.
He also said that when age groups were compared, the average predicted risk for those ages 30 to 49 stayed flat from the midpoint to the late period compared to people age 50 and above.
Source: ANI
SPH
Mitral Valve Regurgitation and Mitral Valve Replacement
Mitral valve replacement is replacing the diseased mitral valve with an artificial valve.
Advertisement
"This is highly relevant to public health because most people think the risk of heart disease is going down steadily and has for the past 30 to 40 years -but our data show something different," Dr. Lopez-Jimenez said.
"The fact is that despite all the wonderful things we've done - all the changes in fat consumption, the promotion of exercise, the quitting smoking, treatment of high cholesterol and blood pressure - it doesn't appear to be enough; the risk reduction we did achieve early on in the 1980s has gone flat, and we need to change that," he added.
For their study, the researchers compared national heart disease risk factor data from three time periods to track change over time in risk reduction.
While early period documented changes in risk between 1976 and 1980 and a midpoint of 1988 to 1994, the last period documented changes in risk from the midpoint to 1999 to 2004.
The team said that comparing changes from the early stage to the midpoint documented a decline in the overall risk to develop heart disease, but comparing change from the midpoint to the late period showed the trend flattening.
"No one has ever compared national data this way, which is why we are the first to detect this worrisome flattening of the trend in risk factor reduction," Dr. Lopez-Jimenez says.
He said that for women, in particular, the age-adjusted risk declined from the early period to the midpoint, but stayed flat from the midpoint to the late period.
He also said that when age groups were compared, the average predicted risk for those ages 30 to 49 stayed flat from the midpoint to the late period compared to people age 50 and above.
Source: ANI
SPH
Ventricular Septal Defect (VSD) - Animation
Animation and slides with sound on 'Ventricular septal defect (VSD)' illustrating the dynamics and treatment of the abnormal hole in septal wall of ventricles
Advertisement
 Atrial Septal Defect or ASD - AnimationAnimation and slides of 'Atrial septal defect (ASD)' illustrating the dynamics and treatment of the abnormal hole in septal wall of upper chambers of the heart. | Advertisement
|
Advertisement
Recommended Reading
Latest Heart Disease News
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
Researchers analyzed the link between muscle strength and the risk of developing heart failure in patients who had a heart attack without prior history of complications.
Heart health scores for gay and bisexual men were 2.72 and 0.83 points superior, respectively, compared to heterosexual men.